{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T14:09:59Z","timestamp":1780668599340,"version":"3.54.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.suronc.2026.102422","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T15:25:36Z","timestamp":1775575536000},"page":"102422","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Prognostic impact of CRM-status on survival in patients with resected pancreatic adenocarcinoma \u2013 a dual-center cohort analysis"],"prefix":"10.1016","volume":"66","author":[{"given":"Maximilian","family":"Brunner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Merkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Cammann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Vondran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Gr\u00fctzmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Wiltberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.suronc.2026.102422_bib1","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/S2468-1253(19)30347-4","article-title":"The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017","volume":"4","year":"2019","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.suronc.2026.102422_bib2","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.suronc.2026.102422_bib3","unstructured":"Krebs in Deutschland F\u00fcr 2017\/2018. 13. Ausgabe. Robert Koch-Institut (Hrsg) Und Die Gesellschaft Der Epidemiologischen Krebsregister in Deutschland E.V. (Hrsg). Berlin, 2021."},{"issue":"18","key":"10.1016\/j.suronc.2026.102422_bib4","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.3390\/ijms20184543","article-title":"Current clinical strategies of pancreatic cancer treatment and open molecular questions","volume":"20","author":"Brunner","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.suronc.2026.102422_bib5","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1245\/s10434-018-6558-7","article-title":"Implications of the pattern of disease recurrence on survival following pancreatectomy for pancreatic ductal adenocarcinoma","volume":"25","author":"Groot","year":"2018","journal-title":"Ann. Surg Oncol."},{"issue":"6","key":"10.1016\/j.suronc.2026.102422_bib6","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.pan.2024.07.017","article-title":"Recurrence pattern and its risk factors in patients with resected pancreatic ductal adenocarcinoma - a retrospective analysis of 272 patients","volume":"24","author":"Brunner","year":"2024","journal-title":"Pancreatology"},{"issue":"6","key":"10.1016\/j.suronc.2026.102422_bib7","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1055\/a-1771-6811","article-title":"S3-Leitlinie zum exokrinen pankreaskarzinom \u2013 kurzversion 2.0 \u2013 dezember 2021, AWMF-Registernummer: 032\/010OL","volume":"60","author":"Seufferlein","year":"2022","journal-title":"Z. Gastroenterol."},{"issue":"10","key":"10.1016\/j.suronc.2026.102422_bib8","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/bjs.5397","article-title":"Redefining the R1 resection in pancreatic cancer","volume":"93","author":"Verbeke","year":"2006","journal-title":"Br. J. Surg."},{"issue":"6","key":"10.1016\/j.suronc.2026.102422_bib9","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1245\/s10434-008-9839-8","article-title":"Most pancreatic cancer resections are R1 resections","volume":"15","author":"Esposito","year":"2008","journal-title":"Ann. Surg Oncol."},{"issue":"3","key":"10.1016\/j.suronc.2026.102422_bib10","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.pan.2020.01.004","article-title":"Prospective assessment of resection margin status following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma after standardisation of margin definitions","volume":"20","author":"Pine","year":"2020","journal-title":"Pancreatology"},{"issue":"2","key":"10.1016\/j.suronc.2026.102422_bib11","doi-asserted-by":"crossref","DOI":"10.1093\/bjsopen\/zrac010","article-title":"Prognostic relevance of the revised R status definition in pancreatic cancer: meta-analysis","volume":"6","author":"Leonhardt","year":"2022","journal-title":"BJS Open"},{"issue":"7","key":"10.1016\/j.suronc.2026.102422_bib12","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.pan.2024.09.003","article-title":"Prognostic significance of involvement of the circumferential resection margin\/surface in patients with pancreatic head cancer: a prospective evaluation of pancreatoduodenectomy specimens using the 0 and 1 mm rules","volume":"24","author":"Kim","year":"2024","journal-title":"Pancreatology"},{"issue":"1","key":"10.1016\/j.suronc.2026.102422_bib13","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1186\/s12885-024-12995-z","article-title":"Prognostic value of the CRM-Status in pancreatic ductal adenocarcinoma - data from a regional cancer registry","volume":"24","author":"Schuhbaur","year":"2024","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.suronc.2026.102422_bib14","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.3390\/cancers2042001","article-title":"Definition of microscopic tumor clearance (r0) in pancreatic cancer resections","volume":"2","author":"Schlitter","year":"2010","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.suronc.2026.102422_bib15","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/SLA.0000000000002432","article-title":"Prognostic value of resection margin involvement after pancreaticoduodenectomy for ductal adenocarcinoma: updates from a French prospective multicenter study","volume":"266","author":"Delpero","year":"2017","journal-title":"Ann. Surg."},{"issue":"17","key":"10.1016\/j.suronc.2026.102422_bib16","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1200\/JCO.2008.20.5104","article-title":"Margin clearance and outcome in resected pancreatic cancer","volume":"27","author":"Chang","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.suronc.2026.102422_bib17","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1002\/bjs.9892","article-title":"Meta-analysis of radical resection rates and margin assessment in pancreatic cancer","volume":"102","author":"Chandrasegaram","year":"2015","journal-title":"Br. J. Surg."},{"issue":"7","key":"10.1016\/j.suronc.2026.102422_bib18","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1097\/MPA.0000000000001106","article-title":"Pathologic evaluation of surgical margins in pancreatic cancer specimens using color coding with tissue marking dyes","volume":"47","author":"Takahashi","year":"2018","journal-title":"Pancreas"},{"issue":"3","key":"10.1016\/j.suronc.2026.102422_bib19","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/SLA.0000000000002557","article-title":"European study group for pancreatic cancer. The impact of positive resection margins on survival and recurrence following resection and adjuvant chemotherapy for pancreatic ductal adenocarcinoma","volume":"269","author":"Ghaneh","year":"2019","journal-title":"Ann. Surg."},{"issue":"11","key":"10.1016\/j.suronc.2026.102422_bib20","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1200\/JCO.21.02233","article-title":"Neoadjuvant chemoradiotherapy versus upfront surgery for resectable and borderline resectable pancreatic cancer: Long-Term results of the Dutch randomized PREOPANC trial","volume":"40","author":"Versteijne","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.suronc.2026.102422_bib21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.annonc.2022.09.161","article-title":"Perioperative or only adjuvant gemcitabine plus nab-paclitaxel for resectable pancreatic cancer (NEONAX)-a randomized phase II trial of the AIO pancreatic cancer group","volume":"34","author":"Seufferlein","year":"2023","journal-title":"Ann. Oncol."},{"issue":"7","key":"10.1016\/j.suronc.2026.102422_bib22","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s11605-018-3995-3","article-title":"Optimal extent of superior mesenteric artery dissection during pancreaticoduodenectomy for pancreatic cancer: balancing surgical and oncological safety","volume":"23","author":"Inoue","year":"2019","journal-title":"J. Gastrointest. Surg."},{"issue":"4","key":"10.1016\/j.suronc.2026.102422_bib23","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.pan.2021.02.024","article-title":"Mesopancreatic excision for pancreatic ductal adenocarcinoma improves local disease control and survival","volume":"21","author":"Safi","year":"2021","journal-title":"Pancreatology"}],"container-title":["Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740426000733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740426000733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T13:07:40Z","timestamp":1780664860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960740426000733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":23,"alternative-id":["S0960740426000733"],"URL":"https:\/\/doi.org\/10.1016\/j.suronc.2026.102422","relation":{},"ISSN":["0960-7404"],"issn-type":[{"value":"0960-7404","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic impact of CRM-status on survival in patients with resected pancreatic adenocarcinoma \u2013 a dual-center cohort analysis","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suronc.2026.102422","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102422"}}